Mounjaro®
Starting from £179.99/mo
Start journey Learn moreFeeling cold and tired on Mounjaro is a recognised pattern, and there is a biological reason for it. As your body takes in fewer calories, it produces less heat and has less fuel for day-to-day energy — both are documented effects seen in clinical trials, not signs that something has gone wrong. These are prescription-only medicines, and a clinician assesses your suitability before treatment begins. If symptoms are severe or persistent, your prescriber needs to know. The NHS tirzepatide page lists fatigue and related symptoms among the reported effects worth monitoring.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
In the SURMOUNT-1 trial, published in the New England Journal of Medicine, participants on the highest tirzepatide doses lost around 20–21% of their body weight over 72 weeks. That scale of weight reduction is significant metabolically. Adipose tissue generates heat; as fat mass falls, the body simply produces less of it. Muscle also plays a role in thermogenesis, and because aggressive calorie restriction can reduce lean mass alongside fat, participants sometimes notice a reduced tolerance to cold environments, particularly in their hands and feet.
Fatigue follows a similar logic. When calorie intake drops sharply, the body's short-term energy availability falls with it. Tirzepatide reduces appetite markedly, which is the mechanism behind its effectiveness, but that appetite suppression can mean some people are eating significantly less than they realise. The result can feel like a general flatness: less drive, earlier tiredness, more need for rest. This is explored further on our page about fatigue and Mounjaro.
Fatigue is listed among the reported side effects of tirzepatide and tends to cluster around the start of treatment and the days following a dose increase, when the appetite-suppressing effect is at its sharpest. Most people notice it easing within a couple of weeks at any given dose.
One practical habit worth building: before you assume the cold or the tiredness is the medicine itself, check what you have actually eaten that day. Many people on tirzepatide find they have consumed very little without noticing, because the urge to eat simply was not there. A quick mental tally (or a glance at any food diary you keep) takes under a minute and can reveal whether you are consistently under-fuelling.
Protein is particularly important here. It is more thermogenic than carbohydrate or fat, meaning the body generates more heat digesting it, and it preserves lean muscle mass that contributes to ongoing calorie burn. Getting adequate protein across meals, even small ones, tends to reduce both the cold feeling and the energy dip. Hydration matters too; dehydration amplifies fatigue and is easy to underestimate when appetite is low and thirst cues are dampened.
If cost or treatment planning is on your mind alongside these symptoms, our Mounjaro cost context page covers what UK private treatment typically includes. The short version is that clinical support for exactly these kinds of questions is built in.
Most cold intolerance and fatigue on Mounjaro is benign and transient. Some situations deserve more attention. If you feel severely or persistently cold in a way that seems disproportionate to the weather or your weight loss so far, it is worth raising with your prescriber, underactive thyroid, anaemia and other conditions can produce the same symptoms and may need ruling out. These are not caused by tirzepatide, but they can be unmasked when someone is eating less and their system is under increased metabolic pressure.
Fatigue that does not improve between dose increases, or that is accompanied by symptoms such as dizziness, palpitations, or feeling faint when standing, also warrants a conversation. Our full Mounjaro side effects overview covers the broader symptom picture, including the signs that need urgent attention.
For context on the mechanism behind tirzepatide's effects, the explanation of why tirzepatide affects energy levels goes into more detail on the dual GIP and GLP-1 pathway. And if you are finding other unexpected symptoms alongside the fatigue (burping is a common one) the gastric-emptying piece on burping explains the shared root cause.
Tirzepatide is a prescription-only medicine for weight management in the UK, assessed and prescribed by a GPhC-registered clinician. What that means in practice is that you should never be navigating symptoms alone. If something feels off, the right move is to contact your prescriber, not to wait it out and hope for the best.
At nume, our prescribers are reachable seven days a week for aftercare. Cold intolerance and tiredness are among the most common questions they hear, particularly in the first month of treatment and after moving to a higher dose. If you are weighing up whether to start, our treatment consultation page is the place to ask those questions directly. A real clinician reads your consultation the same day; there is no automated triage standing between you and a qualified answer.
You can also read about how we approach clinical oversight on our about us page, or explore the wider evidence for weight-loss treatment options through our weight-loss treatments overview.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.